Advertisement

Adherence

  • Nienke Ipenburg
Chapter

Abstract

Inflammatory bowel disease (IBD) is an unpredictable, complex and chronic condition with symptoms that are unpleasant, embarrassing and painful. The global incidence is rising though the majority of patients will remain capable of leading a reasonably normal life (Haynes 1979). Individuals with IBD will often require intensive on-going input from health professionals. The chronic nature and increasing incidence of IBD demand health care innovations to guarantee future high-quality care. This chapter considers specific considerations for nurses and other health care professionals managing adherence in IBD to improve the quality of care. Understanding the patient perspective and being willing to listen to them might be the keys to change.

Keywords

Adherence Medication IBD Chronic illness Compliance Quality of life Self-management E-health 

References

  1. Fishbein M, Yzer MC (2006) Using theory to design effective health behavior interventions. Commun Theory 13(2):164–183.  https://doi.org/10.1111/j.1468-2885.2003.tb00287.x CrossRefGoogle Scholar
  2. Greenle RN, Kunz JH, Walter J, Hommel KA (2013) Practical strategies for enhancing adherence to treatment regimen in inflammatory bowel disease. Inflamm Bowel Dis 19:1534–1545CrossRefGoogle Scholar
  3. Haynes RB (1979) Introduction. In: Haynes RB, Taylor DW, Sackett DL (eds) Compliance in health care. Johns Hopkins University Press, Baltimore, pp 1–7Google Scholar
  4. Haynes RB, McDonald H, Garg AX, Montague P (2002) Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst Rev 2:CD000011Google Scholar
  5. Horne R, Parham R, Driscoll R, Robinson A (2009) Patients attitudes to medicines and adherence to maintenance treatment in inflammatory bowel disease. Inflamm Bowel Dis 15(6):837–844.  https://doi.org/10.1002/ibd.20846 CrossRefPubMedGoogle Scholar
  6. Johnson FR, Özdemir S, Mansfield C, Hass S, Miller DW, Siegel CA, Sands BE (2007) Crohn’s disease patients’ risk-benefit preferences: serious adverse event risks versus treatment efficacy. Gastroenterology 133(3):769–779.  https://doi.org/10.1053/j.gastro.2007.04.075 CrossRefPubMedGoogle Scholar
  7. Linn AJ, van Weert JCM, Schouten BC, Smit EG, van Bodegraven AA, van Dijk L (2012) Words that make pills easier to swallow: a communication typology to address practical and perceptual barriers to medication intake behavior. Patient Prefer Adherence 6:871–885CrossRefGoogle Scholar
  8. Linn AJ, Weert JMC, Smit EG, Perry K, van Dijk L (2013a) The systematic development of a theoretical and evidence-based tailored multimedia intervention to improve medication adherence. Patient Educ Couns 93:381–388.  https://doi.org/10.1016/j.pec.2013.03.009 CrossRefPubMedGoogle Scholar
  9. Linn AJ, van Dijk L, Smit EG, Jansen J, van Weert JCM (2013b) May you never forget what is worth remembering: the relation between recall of medical information and medication adherence in patients with inflammatory bowel disease. J Crohns Colitis 7(11):e543–e550.  https://doi.org/10.1016/j.crohns.2013.04.001 CrossRefPubMedGoogle Scholar
  10. Sabaté E (2003) Adherence to long-term therapies: evidence for action. N Engl J Med 353(5):487–497Google Scholar
  11. Sewitch MJ, Abrahamowicz M, Barkun A, Bitton A, Wild GE, Cohen A, Dobkin PL (2003) Patient nonadherence to medication in inflammatory bowel disease. Am J Gastroenterol 98(7):1535–1544.  https://doi.org/10.1111/j.1572-0241.2003.07522.x CrossRefPubMedGoogle Scholar
  12. Shale M, Riley S (2003) Studies of compliance with delayed-release mesalazine therapy in patients with inflammatory bowel disease. Aliment Pharmacol Ther 18(2):191–198.  https://doi.org/10.1046/j.1365-2036.2003.01648.x CrossRefPubMedGoogle Scholar
  13. van der Have M, Oldenburg B, Kaptein AA, Jansen JM, Scheffer RC, van Tuyl BA, van der Meulen-de Jong AE, Pierik M, Siersema PD, van Oijen MG, Fidder HH (2016) Non-adherence to anti-TNF therapy is associated with illness perceptions and clinical outcomes in outpatients with inflammatory bowel disease: results from a prospective multicentre study. J Crohns Colitis 10(5):549–555.  https://doi.org/10.1093/ecco-jcc/jjw002 CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Nienke Ipenburg
    • 1
  1. 1.IJsselland HospitalCapelle aan den IjsselThe Netherlands

Personalised recommendations